Proposed changes to IP policy are changing the way and degree to which innovative technologies are being protected, developed and commercialized. This panel of seasoned technology licensing directors addresses the current and future changes to how they do business in the face of this shifting environment.

Objective1:Learn about topical issues in IP policy and how they are affecting biotechnology business practices.

Objective2:Present solutions and organizational approaches to address new best practices needed for technology transfer.

Objective3:"Present and discuss models that are emerging to support licensing, commercializtion, and startups in an increasing interactive and multifaced technology transfer lanscape."